🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Dietary Advanced Glycation End Products Induced Anxiety- and Depression-like Behaviors in Female C57BL/6 Mice and the Ameliorative Effects of Quercetin.

PMID: 41962780 · DOI: 10.1016/j.jnutbio.2026.110363 · The Journal of nutritional biochemistry, 2026 · Tongtong Ma, Zhilong He, Guoqi Yang, Jijiao Cai, Li-Qiang Qin, Yu Xia, Zhongxiao Wan
📄 Abstract

Quercetin is a flavonoid bioactive compound with potential anti-depression effect. Dietary advanced glycation end products (AGEs) might be critically associated with depression. We aimed to explore whether quercetin ameliorates dietary AGEs-induced anxiety and depression-like behaviors in female mice, with a focus on hypothalamic-pituitary-adrenal axis (HPA) regulation and gut microbiota composition. Mice were divided into three groups: control, dietary AGEs, and AGEs plus quercetin. Dietary AGEs induced anxiety and depression-like behavioral effects, reduced BDNF, P-CREB, PSD95, doublecortin, and synaptophysin protein expression. Dietary AGEs induced HPA axis overactivation has been confirmed by decreased hippocampal GR, P-GR S211, and arginase-1, and elevated FKBP51, NLRP3, caspase-1, and p65 protein expression. Dietary AGEs resulted in gut microbiota disorder and correlation analysis revealed significant associations between Proteobacteria, the [Eubacterium] coprostanoligenes group, Klebsiella and Lachnospiraceae_NK4A136_group with behavioral parameters. Quercetin intervention improved dietary AGEs associated anxiety and depression-like behavioral effects via restoring HPA axis and gut microbiota.

Confidence: 0.26 · 13 полей извлечено
Идентификация (6 полей)
Target
Quercetin
0.95
Alt. target
0.00
Protein family
Flavonoid
0.90
Functional class
Bioactive compound
0.80
Subcellular loc.
0.00
Isoforms (metab/obesity)
0.00
Механизм действия (21 полей)
Mechanism
0.00
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
0.00
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
0.00
Cell death
0.00
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
0.00
Downstream (physiol)
0.00
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
hippocampal GR, P-GR S211, arginase-1, FKBP51, NLRP3, caspase-1, p65, BDNF, P-CREB, PSD95, doublecortin, synaptophysin
0.90
In vitro
0.00
In vivo
female C57BL/6 mice divided into three groups: control, dietary AGEs, and AGEs plus quercetin
0.95
In silico
0.00
Genetic association
0.00
Ex vivo
0.00
Animal model
female C57BL/6 mice
0.95
Diet/model
dietary advanced glycation end products (AGEs)
0.95
Клиника (11 полей)
Drug
Quercetin
0.95
Indication
Anxiety and depression-like behaviors induced by dietary advanced glycation end products
0.90
Patient subgroups
Female C57BL/6 mice
0.85
Safety concerns
0.00
Off-target
0.00
Trial stage
Preclinical (animal study)
0.90
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
Improved anxiety and depression-like behavioral effects, restored HPA axis, and gut microbiota composition
0.90
Approved
False
0.95